Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
752 | 3104 | 40.2 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
427 | 3 | JOURNAL OF THE INSTITUTE OF BREWING//KERATINASE//CYSTATIN | 27946 |
1744 | 2 | CATHEPSIN//CATHEPSIN K//CATHEPSIN B | 6503 |
752 | 1 | CATHEPSIN B//CYSTATIN//CATHEPSIN L | 3104 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CATHEPSIN B | authKW | 1145230 | 11% | 36% | 327 |
2 | CYSTATIN | authKW | 841823 | 7% | 39% | 217 |
3 | CATHEPSIN L | authKW | 712096 | 6% | 38% | 192 |
4 | CATHEPSIN | authKW | 529572 | 7% | 25% | 215 |
5 | STEFIN | authKW | 371132 | 1% | 88% | 43 |
6 | CYSTEINE PROTEASE | authKW | 278745 | 6% | 16% | 180 |
7 | CYSTEINE PROTEINASE INHIBITOR | authKW | 236512 | 2% | 38% | 63 |
8 | BIOCHEM DRUG DESIGN | address | 201469 | 1% | 79% | 26 |
9 | CATHEPSINS | authKW | 197818 | 3% | 21% | 94 |
10 | CATHEPSIN X | authKW | 179683 | 1% | 70% | 26 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 10900 | 50% | 0% | 1537 |
2 | Biophysics | 2852 | 12% | 0% | 368 |
3 | Cell Biology | 2036 | 15% | 0% | 458 |
4 | Oncology | 1399 | 13% | 0% | 399 |
5 | Medicine, Research & Experimental | 207 | 4% | 0% | 132 |
6 | Chemistry, Medicinal | 188 | 3% | 0% | 96 |
7 | Pathology | 186 | 3% | 0% | 90 |
8 | Immunology | 114 | 5% | 0% | 151 |
9 | Biochemical Research Methods | 84 | 3% | 0% | 85 |
10 | Dermatology | 77 | 2% | 0% | 54 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM DRUG DESIGN | 201469 | 1% | 79% | 26 |
2 | BIOCHEM MOL STRUCT BIOL | 69219 | 1% | 19% | 38 |
3 | GENET TOXICOL CANC BIOL | 65042 | 1% | 22% | 30 |
4 | UPPSALA BIOMED VET MED CHEM BOX 575 | 49178 | 0% | 100% | 5 |
5 | MOL MED CELL | 36265 | 1% | 11% | 34 |
6 | BIOCHEM RADIAT BIOL | 33184 | 0% | 38% | 9 |
7 | MOL MED ZELLFOR | 31190 | 1% | 16% | 20 |
8 | ABT KLIN CHEM BAKTERIOL | 29507 | 0% | 100% | 3 |
9 | LUDWIG HEILMEYER COMPREHENS CANC | 29507 | 0% | 100% | 3 |
10 | PROV ANIM OURCE EPIDEM DIS PREVENT | 27317 | 0% | 56% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL CHEMISTRY | 37775 | 4% | 3% | 111 |
2 | BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 31532 | 2% | 5% | 70 |
3 | BIOCHEMICAL JOURNAL | 3703 | 3% | 0% | 107 |
4 | BIOMEDICA BIOCHIMICA ACTA | 3438 | 1% | 1% | 27 |
5 | FEBS LETTERS | 3200 | 4% | 0% | 118 |
6 | JOURNAL OF BIOCHEMISTRY | 2784 | 2% | 1% | 56 |
7 | FISH & SHELLFISH IMMUNOLOGY | 1460 | 1% | 1% | 26 |
8 | VOPROSY MEDITSINSKOI KHIMII | 1351 | 1% | 1% | 18 |
9 | ACTA HISTOCHEMICA | 1263 | 1% | 1% | 19 |
10 | NEOPLASMA | 1233 | 1% | 1% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATHEPSIN B | 1145230 | 11% | 36% | 327 | Search CATHEPSIN+B | Search CATHEPSIN+B |
2 | CYSTATIN | 841823 | 7% | 39% | 217 | Search CYSTATIN | Search CYSTATIN |
3 | CATHEPSIN L | 712096 | 6% | 38% | 192 | Search CATHEPSIN+L | Search CATHEPSIN+L |
4 | CATHEPSIN | 529572 | 7% | 25% | 215 | Search CATHEPSIN | Search CATHEPSIN |
5 | STEFIN | 371132 | 1% | 88% | 43 | Search STEFIN | Search STEFIN |
6 | CYSTEINE PROTEASE | 278745 | 6% | 16% | 180 | Search CYSTEINE+PROTEASE | Search CYSTEINE+PROTEASE |
7 | CYSTEINE PROTEINASE INHIBITOR | 236512 | 2% | 38% | 63 | Search CYSTEINE+PROTEINASE+INHIBITOR | Search CYSTEINE+PROTEINASE+INHIBITOR |
8 | CATHEPSINS | 197818 | 3% | 21% | 94 | Search CATHEPSINS | Search CATHEPSINS |
9 | CATHEPSIN X | 179683 | 1% | 70% | 26 | Search CATHEPSIN+X | Search CATHEPSIN+X |
10 | CYSTEINE PROTEASE INHIBITOR | 176717 | 2% | 29% | 61 | Search CYSTEINE+PROTEASE+INHIBITOR | Search CYSTEINE+PROTEASE+INHIBITOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KIRSCHKE, H , BARRETT, AJ , RAWLINGS, ND , (1995) PROTEINASES .1. LYSOSOMAL CYSTEINE PROTEINASES.PROTEIN PROFILE. VOL. 2. ISSUE 14. P. 1587 -1643 | 564 | 58% | 101 |
2 | TURK, V , STOKA, V , VASILJEVA, O , RENKO, M , SUN, T , TURK, B , TURK, D , (2012) CYSTEINE CATHEPSINS: FROM STRUCTURE, FUNCTION AND REGULATION TO NEW FRONTIERS.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. VOL. 1824. ISSUE 1. P. 68 -88 | 201 | 60% | 218 |
3 | SUDHAN, DR , SIEMANN, DW , (2015) CATHEPSIN L TARGETING IN CANCER TREATMENT.PHARMACOLOGY & THERAPEUTICS. VOL. 155. ISSUE . P. 105 -116 | 114 | 59% | 5 |
4 | KOS, J , MITROVIC, A , MIRKOVIC, B , (2014) THE CURRENT STAGE OF CATHEPSIN B INHIBITORS AS POTENTIAL ANTICANCER AGENTS.FUTURE MEDICINAL CHEMISTRY. VOL. 6. ISSUE 11. P. 1355 -1371 | 104 | 66% | 6 |
5 | JEDESZKO, C , SLOANE, BF , (2004) CYSTEINE CATHEPSINS IN HUMAN CANCER.BIOLOGICAL CHEMISTRY. VOL. 385. ISSUE 11. P. 1017-1027 | 92 | 82% | 162 |
6 | MAGISTER, S , KOS, J , (2013) CYSTATINS IN IMMUNE SYSTEM.JOURNAL OF CANCER. VOL. 4. ISSUE 1. P. 45-56 | 93 | 65% | 39 |
7 | BERDOWSKA, I , (2004) CYSTEINE PROTEASES AS DISEASE MARKERS.CLINICA CHIMICA ACTA. VOL. 342. ISSUE 1-2. P. 41-69 | 135 | 59% | 109 |
8 | TURK, V , STOKA, V , TURK, D , (2008) CYSTATINS: BIOCHEMICAL AND STRUCTURAL PROPERTIES, AND MEDICAL RELEVANCE.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 13. ISSUE . P. 5406 -5420 | 95 | 65% | 125 |
9 | KEPPLER, D , (2006) TOWARDS NOVEL ANTI-CANCER STRATEGIES BASED ON CYSTATIN FUNCTION.CANCER LETTERS. VOL. 235. ISSUE 2. P. 159-176 | 112 | 61% | 59 |
10 | DICKINSON, DP , (2002) SALIVARY (SD-TYPE) CYSTATINS: OVER ONE BILLION YEARS IN THE MAKING-BUT TO WHAT PURPOSE?.CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE. VOL. 13. ISSUE 6. P. 485 -508 | 121 | 62% | 56 |
Classes with closest relation at Level 1 |